ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Tobacco Research Council Awards Six New Grants

July 4, 1975

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

Deborah Mayer Appointed To NCAB; Cancer Panel Plans Meetings For July 9

May 10, 1991

New ACR Mammography Guidelines Suggest Annual Screening For Women Age 40-50

November 12, 1982

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976

Committee, BSC Recommend Against Continuing Women’s Health Trial; Appeal to NCAB Seen

January 15, 1988